[AVBP]

Mid

All available information for this ticker. | View Original

Mid 2026-10-25 22:29:40

ArriVent reports phase 1 data for cancer drug ARR-217

Mid 2026-10-06 23:06:53

ArriVent plunges as lead asset fails in late-stage cancer trial

Mid 2026-10-06 21:55:06

ArriVent stock tumbles 60% after trial misses primary endpoint